1.
Annu Int Conf IEEE Eng Med Biol Soc
; 2014: 2346-7, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25570459
RESUMO
Sustained release of a small molecule from a prototype implantable drug delivery device was monitored via MRI in an ex vivo tissue phantom over a period of two days. T1 mapping was used as a method to quantify analyte concentration. Continuous, controlled release was observed. The MRI methodology was thus found to be appropriate for device validation and quality assurance/control.